Wellington Management

AssetWatch is a leading provider of proactive and predictive maintenance solutions focused on eliminating unplanned downtime for global manufacturers. The company specializes in end-to-end remote condition monitoring, utilizing a network of wireless sensors to collect critical machine health data, which is then analyzed through cloud-based software. Leveraging machine learning algorithms and insights from condition monitoring engineers, AssetWatch transforms data into actionable intelligence, enabling manufacturers to adopt a proactive maintenance culture. Their approach enhances the predictive maintenance process with expert prescriptive recommendations that go beyond standard evaluations, thereby supporting organizations in shifting from reactive to proactive maintenance and reliability strategies.

Maza is a mobile application that operates as a digital bank, providing a range of modern banking services. The company offers users access to savings accounts, NFC-enabled prepaid cards for both online and offline transactions, as well as bill payment and money transfer services. Maza aims to deliver a seamless banking experience, allowing users to manage their finances efficiently while maximizing their savings. Through its innovative approach, the company seeks to enhance the way individuals engage with their financial products and services.

Atsena Therapeutics is a clinical-stage gene therapy company dedicated to developing innovative treatments for inherited retinal diseases. The company focuses on therapies for conditions such as X-linked retinoschisis and GUCY2D-associated Leber congenital amaurosis. Utilizing an advanced adeno-associated virus (AAV) technology platform, including a novel spreading capsid, Atsena aims to target specific retinal conditions to prevent blindness resulting from genetic mutations. Their research is centered on providing effective ocular gene therapies that address significant challenges associated with inherited retinal diseases, with the goal of reversing or halting vision loss.

Lumafield is a company that specializes in industrial computed tomography (CT) solutions aimed at non-destructive testing and inspection for engineers. Its flagship product, the Neptune X-ray CT scanner, offers detailed imaging capabilities that allow engineers to analyze internal structures and identify defects in various materials. Complementing this hardware is the Voyager software platform, which provides cloud-based, AI-powered analysis, facilitating automated inspections and collaborative tools for engineers. Additionally, Lumafield's Triton system is engineered for high-speed scanning, catering to high-volume manufacturing processes. The company’s solutions are utilized across multiple industries, including aerospace, automotive, electronics, and medical devices, ultimately enhancing product quality and reliability throughout the development process.

Just Salad is a fast-casual restaurant chain that focuses on providing healthy and affordable meals, specializing in salads, wraps, smoothies, and soups. The company is committed to sustainability, implementing various initiatives such as a Reusable Bowl Program that encourages customers to bring their own containers for discounts, thereby reducing single-use packaging waste. Just Salad was also the first restaurant chain in the U.S. to introduce a carbon-labeled menu, which highlights the environmental impact of each meal. Additionally, the company utilizes compostable packaging and has established recycling programs to further minimize waste. By offering fresh ingredients at accessible prices, Just Salad aims to make health and sustainability compatible with everyday dining.

MedinCell S.A. is a pharmaceutical company focused on developing innovative therapeutic solutions through its proprietary BEPO technology, which facilitates long-acting injectable products utilizing biodegradable polymers and a biocompatible solvent. Based in Jacou, France, the company is engaged in ongoing research and development to optimize the efficiency and accessibility of medical treatments across various therapeutic areas. MedinCell's product pipeline includes several candidates, such as mdc-IRM, a subcutaneous injection for schizophrenia currently in Phase III trials, and mdc-CWM, an intra-articular injection aimed at treating pain and inflammation. Additionally, the company is exploring formulations like mdc-WWM for contraception and mdc-ANG for central nervous system disorders, alongside other candidates targeting pain management and organ transplant applications. Through its advancements in controlled, long-acting injectables, MedinCell aims to enhance treatment outcomes for patients.

Tabby Inc. is a financial technology company based in the United Arab Emirates that offers innovative payment solutions for online and offline shopping. The company specializes in a buy now, pay later service, providing consumers in the UAE and Saudi Arabia with flexible payment options. Customers can choose to pay for their purchases either in a single deferred payment or in multiple installments, allowing them to manage their spending and enhance their shopping experience. Through its platform, Tabby aims to reshape the relationship between consumers and money, promoting financial freedom and responsible spending.

Swanston Labs builds data-driven solutions aimed at disrupting the convergence of media, entertainment, technology, and commerce. The company focuses on leveraging innovative technologies to address the $7 trillion global leisure spending market. Swanston Labs operates under the Swanston Organization, which also includes Swanston Family Ventures and Swanston Philanthropy, collectively advancing the mission of innovation and inclusion.

Helicore Biopharma is a biopharmaceutical company dedicated to developing innovative treatments for obesity and related metabolic disorders. Its portfolio includes novel therapeutics based on glucose-dependent insulinotropic peptide (GIP) antagonism and monoclonal antibodies that bind circulating GIP ligands, forming a modular platform for anti-obesity medicines. The company aims to help patients with obesity and related conditions achieve significant weight loss.

Genius Sports Group Limited, founded in 2000 and headquartered in London, is a leading provider of technology-driven solutions in the sports data and betting industries. Through its subsidiaries, the company offers a range of services, including sports data software for leagues and governing bodies, live betting products, and personalized marketing campaigns for the sports betting sector. Genius Sports has established itself as a trusted partner to numerous international sports organizations, including major federations and professional leagues. Its commitment to the integrity and commercialization of sports data is central to its operations, emphasizing collaboration between sports organizations and data users to ensure both protection and opportunity maximization. The company's offerings are categorized into three main areas: Sports Technology and Services, Betting Technology, and Media Technology, all supported by a robust proprietary data infrastructure. Genius Sports primarily generates revenue from its Betting Technology division and has a significant presence in the European market.

Thoras.ai is an AI cloud management platform..It helps to detection, monitor performance, and manage costs.

Saluda Medical Pty Ltd. is a medical device company specializing in the development of neuromodulation technologies for chronic neurological conditions. Founded in 2010 and based in Artarmon, Australia, with additional offices in the United States and the United Kingdom, Saluda Medical focuses on its innovative Evoke system. This investigational device employs a closed-loop spinal cord stimulation approach that continuously monitors the spinal cord's response to stimulation and adjusts treatment in real-time to optimize patient outcomes. By utilizing a unique dose-control platform, Saluda Medical aims to customize therapy based on individual neural responses, thereby improving the management of chronic pain, particularly in patients suffering from conditions such as neuropathic pain and chronic back pain.

SiteOne Therapeutics is a San Francisco-based company focused on developing innovative therapeutics and diagnostics aimed at treating acute and chronic pain. The company specializes in creating products that address the limitations of existing pain management therapies, such as nonsteroidal anti-inflammatory drugs (NSAIDs) and opioids. Its lead therapeutic candidates are selective inhibitors of the voltage-gated sodium ion channel Naᵥ1.7, which is essential for the generation and conduction of pain signals. By targeting this specific channel, SiteOne Therapeutics aims to provide more effective and safer pain relief options for healthcare professionals and their patients, particularly in the treatment of neuropathic pain.

Databricks Inc. is a technology company that provides a unified data analytics cloud platform designed to facilitate data engineering and collaborative data science. The company offers a comprehensive suite of tools, including a just-in-time data platform that simplifies data integration, real-time experimentation, and deployment of production applications for developers and data scientists. Key products include Databricks Delta, which combines the capabilities of data warehouses with low-latency streaming, MLflow for managing the machine learning lifecycle, and Delta Lake for handling batch and streaming data. Databricks serves a diverse range of industries, including advertising, healthcare, manufacturing, and telecommunications, and has established strategic partnerships with various organizations to enhance its offerings. Founded in 2013, Databricks is headquartered in San Francisco, California, with additional offices in London, Amsterdam, and Bengaluru.

Current is a consumer fintech banking platform dedicated to enhancing financial access for everyday Americans. The company focuses on developing integrated solutions that address the barriers preventing individuals from achieving their financial goals. By simplifying banking processes and providing user-friendly tools, Current aims to empower users to build a secure financial future. With backing from prominent investors, Current continues to innovate in the financial technology space, striving to meet the diverse needs of its customer base through modern banking solutions.

Archer is an aerospace company based in the San Francisco Bay Area, dedicated to advancing sustainable air mobility. The company specializes in designing, manufacturing, and operating all-electric vertical takeoff and landing aircraft aimed at enhancing urban mobility. Archer's flagship aircraft is designed to carry four passengers for up to 60 miles at speeds of up to 150 mph, with minimal noise production.

nChroma Bio is a biotechnology company specializing in targeted genetic medicine. It operates an integrated product engine for safe, accurate, and targeted in vivo administration, aiming to overcome limitations of current genetic medicine techniques. The company focuses on liver-targeted therapies, initially for chronic hepatitis B and D, leveraging epigenetics to enable precise and specific gene regulation. This approach allows for therapies with programmable tissue specificity, potentially offering durable and targeted cures for the liver and other organs.

AMP Robotics Corporation specializes in designing and manufacturing robotic systems for material recovery facilities and recycling operations, focusing on automating the identification, sorting, and processing of complex waste streams. The company's flagship product, AMP Cortex, utilizes advanced robotics and computer vision technology to efficiently pick and sort recyclable materials, significantly lowering sorting costs. Additionally, AMP Neuron, a software solution, captures and analyzes material data to identify features in a manner similar to human perception. By leveraging artificial intelligence and machine learning, AMP Robotics enhances recycling processes for various waste types, including municipal solid waste and e-waste. The modular design of its systems allows for easy integration into existing infrastructure, minimizing disruption and capital investment. Founded in 2014 and headquartered in Louisville, Colorado, AMP Robotics has formed strategic partnerships to further its mission of improving recycling rates and economic recovery of recyclables.

Olema Oncology is a preclinical biotechnology company dedicated to developing innovative therapies for the treatment and prevention of estrogen receptor-positive breast cancer. The company specializes in discovering and commercializing targeted treatments specifically designed for women's cancers. By leveraging its extensive understanding of endocrine-driven cancers, nuclear receptors, and mechanisms of acquired resistance, Olema aims to create compounds that surpass existing therapies. The company's focus is on transforming the standard of care for both pre- and post-menopausal women with cancer, with an emphasis on developing more effective and convenient treatment options. Olema's pipeline includes drug candidates such as OP-1250 and OP-3136, which have progressed through discovery and preclinical studies.

Metsera is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for obesity and metabolic conditions. The company focuses on advancing a variety of treatment options, including both oral and injectable therapies, specifically targeting incretin, non-incretin, and combination approaches. By integrating proprietary health technology tools, Metsera aims to provide personalized care that meets the evolving demands of weight loss treatment. Its commitment to addressing multiple therapeutic targets positions the company to significantly impact the future of obesity management and related metabolic diseases.

Beta Bionics is a biotechnology company focused on developing advanced solutions for diabetes management. Its flagship product, the iLet Bionic Pancreas System, is an integrated device designed to alleviate the burden of diabetes care. This system encompasses a dual-chamber infusion pump that delivers insulin and glucagon with precision and accuracy, autonomously calculating and administering doses to help patients maintain optimal blood sugar levels. The iLet has received breakthrough designation for all its configurations, including insulin-only, glucagon-only, and bihormonal, and it incorporates Zealand Pharma’s dasiglucagon, which is known for its stability in a ready-to-use aqueous solution. Through these innovations, Beta Bionics aims to improve the quality of life for individuals living with diabetes.

Crescent Biopharma is a biotechnology firm focused on developing novel precision-engineered medicines targeting verified biology to improve care for patients with solid tumors.

Crisp, Inc. is a technology company established in 2018 and headquartered in Brooklyn, New York, that specializes in demand forecasting software tailored for the food industry. The company offers a data platform that connects consumer packaged goods (CPG) brands with real-time point-of-sale and inventory data from over 40 retailers and distributors. By leveraging advanced analytics and business intelligence tools, Crisp provides actionable insights through interactive dashboards, enabling nearly 6,000 CPGs to optimize sales and supply chain operations. The platform's primary aim is to enhance efficiency within the food supply chain, helping retailers and suppliers manage inventory effectively while reducing waste.

Trace Machina is a technology company that develops and maintains open-source simulation infrastructure. It focuses on advanced technologies such as AI, robotics, and autonomous mobility to reduce simulation costs for safety-critical systems, making it more affordable for builders to create and test futuristic technologies using existing infrastructure and tools.

Mindset is a company that specializes in providing assistance to individuals with mental illness and their caregivers in navigating the process of applying for Social Security Disability benefits. The firm offers comprehensive guidance to help patients secure Social Security Disability Insurance benefits, which can cover essential living expenses and medical bills. Additionally, Mindset provides round-the-clock monitoring to support clients in maximizing their benefits, ensuring that those with physical impairments receive the necessary resources for a more manageable lifestyle. Through its services, Mindset aims to alleviate the challenges faced by individuals seeking financial support due to their disabilities.

Abnormal Security Corporation is a San Francisco-based company that specializes in cloud-based email security solutions for Microsoft Office 365 and G Suite. Founded in 2018, the company provides a comprehensive platform designed to protect enterprises from targeted email attacks. Utilizing a data science approach, Abnormal Security offers features such as inbound email protection, detection of email account compromises, and response capabilities. Its technology includes Abnormal Behavior Technology, which models identities of both employees and external senders, profiles relationships, and analyzes email content to prevent threats like credential phishing, internal phishing, employee impersonation, and invoice fraud. The company primarily serves industries including financial services, healthcare, and oil, gas, and utilities, aiming to mitigate risks related to account takeovers and financial losses.

MBX Biosciences, Inc. is a biotechnology company founded in 2018 and based in Carmel, Indiana. The company specializes in developing therapeutics for rare endocrine disorders, focusing on conditions that currently lack effective treatments. MBX Biosciences aims to discover, develop, and commercialize first-in-class therapies, particularly peptides designed to address endocrine genetic diseases that affect glandular hormone production and the body’s chemical messaging systems.

Day One Biopharmaceuticals is a clinical-stage biotechnology company dedicated to developing targeted cancer therapies for patients of all ages, with a particular emphasis on pediatric patients who have historically been underserved in cancer treatment advancements. The company is committed to addressing the unique needs of children and adults facing cancer by creating therapies that are informed by the biology of childhood cancers. Day One Biopharmaceuticals aims to bring promising treatments rapidly to market, focusing on those that can benefit both younger and older patients. The company's lead product candidate, DAY101, is an oral, brain-penetrant pan-RAF kinase inhibitor designed to target genetically defined cancers. By licensing and acquiring innovative products from research institutions and other biopharmaceutical companies, Day One Biopharmaceuticals seeks to provide effective treatment options for families confronted with the challenges of a cancer diagnosis.

Scorpion Therapeutics, Inc. is a clinical-stage biotechnology company based in Boston, Massachusetts, focused on advancing precision oncology for cancer treatment. Founded in 2020, the company specializes in developing targeted small-molecule drugs that address validated cancer targets, as well as previously undruggable and novel targets. Scorpion Therapeutics utilizes an integrated approach that combines target discovery, medicinal chemistry, and translational medicine to create a diverse pipeline of optimized compounds. By leveraging its precision medicine platform, the company aims to enhance the efficacy of cancer therapies and expand treatment options for patients, ultimately striving to overcome the limitations of existing cancer treatments.

Element Biosciences, Inc., established in 2017 and headquartered in San Diego, California, specializes in developing innovative genetic analysis tools for research and diagnostic markets. The company's core business revolves around its disruptive DNA sequencing technology, which encompasses surface chemistry, sequencing chemistry, detection methods, and data analysis. Element Biosciences aims to enhance accessibility to next-generation sequencing by offering a modular, high-performing platform that delivers high-quality data and workflow flexibility, thereby reducing run and capital costs.

TS Conductor is a company focused on providing high-performance conductors for modern power grids. It specializes in the development of advanced transmission technology that features a carbon-fiber-composite core, replacing the traditional steel core. This innovative design results in conductors that are both lighter and stronger, enabling them to carry higher electrical currents with reduced energy loss and enhanced efficiency. The company manufactures conductors with aluminum encapsulation, which protects the composite core from damage and corrosion. Through its products, TS Conductor aims to enhance capacity and reliability in the energy industry while promoting sustainable practices in electricity transmission and distribution.

Savara is an orphan lung disease company. Savara’s pipeline comprises Molgradex, an inhaled granulocyte-macrophage colony-stimulating factor, or GM-CSF, in Phase 3 development for autoimmune pulmonary alveolar proteinosis, or aPAP, in Phase 2a development for nontuberculous mycobacteria, or NTM, lung infection, and in preparation for Phase 2a development in cystic fibrosis, or CF, affected individuals with chronic NTM lung infection; and AeroVanc, a Phase 3 stage inhaled vancomycin for treatment of persistent methicillin resistant staphylococcus aureus, or MRSA, lung infection in CF. Savara’s strategy involves expanding its pipeline of potentially best-in-class products through indication expansion, strategic development partnerships and product acquisitions, with the goal of becoming a leading company in its field. The most recent acquisition is aerosolized amikacin/fosfomycin, a Phase 2 ready, proprietary combination antibiotic, which has demonstrated potent and broad-spectrum antibacterial activity against highly drug resistant pathogens. Savara’s management team has significant experience in orphan drug development and pulmonary medicine, identifying unmet needs, developing and acquiring new product candidates, and effectively advancing them to approvals and commercialization.

GrayMatter Robotics is a company specializing in advanced robotics solutions tailored for high-mix, low-volume manufacturing environments. The firm addresses complex surface treatment and finishing challenges faced by manufacturers through its innovative robotic systems and proprietary artificial intelligence technologies. These smart robotic cells are designed to assist human operators with tedious and ergonomically demanding tasks, enhancing efficiency and productivity. By integrating AI capabilities into its robots, GrayMatter Robotics enables clients to streamline complex operations, ultimately improving their operational effectiveness and addressing the unique needs of diverse manufacturing processes.

Disc Medicine, Inc. is a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, focused on developing innovative treatments for severe hematologic disorders. Founded in 2017, the company specializes in human genetics-based therapeutics that aim to improve red blood cell production in patients suffering from various hematologic diseases. Disc Medicine's pipeline includes therapeutic candidates targeting critical pathways involved in red blood cell biology, such as heme biosynthesis and iron homeostasis. Notable programs include bitopertin, which is being developed for conditions like erythropoietic porphyrias and Diamond-Blackfan anemia. Through its research and development efforts, Disc Medicine seeks to transform the lives of patients affected by these challenging disorders.

Cargo Therapeutics is a clinical-stage biotechnology company focused on developing innovative CAR T-cell therapies to improve outcomes for cancer patients. The company aims to address the challenges faced by existing autologous CAR therapies, which are only curative for less than half of cancer patients and hindered by issues such as manufacturing limitations, supply challenges, and reimbursement barriers. Cargo Therapeutics is advancing next-generation cell therapies designed to enhance effectiveness, safety, and supply reliability. One of its key products, CRG-022, is a novel CAR T-cell candidate targeting CD22, an antigen present in a majority of B-cell malignancies, specifically designed to overcome treatment resistance. By pursuing these novel solutions, Cargo Therapeutics seeks to facilitate broader access to curative therapies and significantly improve the treatment experience for cancer patients.

Scale AI, Inc. is a data platform provider specializing in training and validation data for artificial intelligence applications. Founded in 2016 and headquartered in San Francisco, the company offers various annotation tools including Scale Image for image data, Scale Video for video data, Scale Text for text data, and Scale Document for intelligent document processing. Its advanced platform also includes Scale Nucleus, which helps manage user data. Scale AI's products support a wide range of sectors, such as autonomous vehicles, retail, conversational AI, and robotics, facilitating tasks like content moderation and transcription. By focusing on providing high-quality labeled data, Scale AI enables organizations to accelerate the development of AI technologies, allowing clients to concentrate on building innovative models rather than data preparation.

Bluejay Therapeutics is a private biopharmaceutical company dedicated to developing curative treatments for infectious diseases, with an initial focus on chronic Hepatitis B. This disease remains prevalent worldwide and has significant unmet medical needs. The company is pursuing two innovative approaches: fully human IgG1 anti-HBs monoclonal antibodies and first-in-class HBsAg oral small molecule inhibitors. These therapies aim to reduce hepatitis B surface antigen levels and restore adaptive immunity, potentially achieving a functional cure for patients.

Zenas BioPharma is a clinical-stage biopharmaceutical company headquartered in Florida, USA, that specializes in developing immune-based therapies for patients. The company’s lead product candidate, obexelimab, is a bifunctional monoclonal antibody designed to target both CD19 and FcγRIIb, which are found in B cell lineages. This innovative approach aims to inhibit the activity of cells involved in various autoimmune diseases while preserving their presence, thus avoiding depletion. Through its focus on these advanced therapies, Zenas BioPharma seeks to address unmet medical needs in the treatment of autoimmune conditions.

Wiz, Inc. is a cybersecurity company founded in 2020, with headquarters in Palo Alto, California, and an additional office in Tel Aviv, Israel. The company specializes in cloud security, providing enterprises with a platform that enables them to identify security issues within their public cloud infrastructure. Wiz's innovative solution offers a comprehensive, cloud-native visibility tool that analyzes the entire cloud environment, delivering a 360-degree view of security risks across various platforms, including clouds, containers, and workloads. The platform utilizes actionable, graph-based analysis to facilitate in-depth risk assessment and root cause analysis without the need for agents, allowing organizations to enhance their security posture effectively.

BridgeBio Oncology Therapeutics is a biopharmaceutical company specializing in the development of precision oncology therapeutics. It focuses on targeting RAS-dependent cancers, leveraging a profound understanding of RAS signaling biology to create drugs that selectively inhibit RAS-driven PI3K activation and a wide spectrum of KRAS mutants. The company aims to provide patients with tailored treatments that address both active and inactive cancer-driving states.

Finvero, founded in January 2021 in Mexico City, operates a credit marketplace that connects merchants with lenders. It enables businesses to offer personalized financing options to their customers, facilitating tasks such as registering businesses and managing various credit products. This platform aims to boost average ticket sales for merchants by providing convenient credit payment solutions.

Asher Biotherapeutics, Inc. is a biotechnology company based in South San Francisco, California, founded in 2019. The company specializes in the development of immunotherapy drugs aimed at effectively treating cancer. Its innovative therapies are designed to enhance the immune system's ability to target and eliminate cancer cells while minimizing side effects. This focus allows healthcare providers to deliver effective treatments to patients in a shorter timeframe, aiming to improve overall outcomes in cancer care.

Obsidian Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, founded in 2015. The company specializes in developing next-generation cell and gene therapies aimed at enhancing adoptive immunotherapy for cancer patients. Its innovative approach utilizes pharmacologic operating systems that enable precise control over protein activity within cells. This technology allows for the creation of adoptive cell therapies with novel functionalities, which can be regulated by treating physicians using simple and safe orally active medications. Through these advancements, Obsidian Therapeutics seeks to improve upon existing cell therapies and expand treatment options for a broader patient demographic.

Avidity Biosciences, Inc. is a biopharmaceutical company based in La Jolla, California, specializing in the development of oligonucleotide-based therapies, particularly through its innovative Antibody Oligonucleotide Conjugates (AOC) platform. This technology aims to address the limitations of traditional oligonucleotide therapies by combining the tissue selectivity of monoclonal antibodies with the precision of oligonucleotide treatments. Avidity's lead product candidate, AOC 1001, targets myotonic dystrophy type 1, a rare genetic muscle disease. In addition to this, the company is advancing multiple programs focused on muscle-related conditions, including muscle atrophy, Duchenne muscular dystrophy, facioscapulohumeral muscular dystrophy, and Pompe disease. Furthermore, Avidity is expanding its research to include immune and other cell types, positioning itself at the forefront of biopharmaceutical innovation for serious diseases.

AssetWatch is a leading provider of proactive and predictive maintenance solutions focused on eliminating unplanned downtime for global manufacturers. The company specializes in end-to-end remote condition monitoring, utilizing a network of wireless sensors to collect critical machine health data, which is then analyzed through cloud-based software. Leveraging machine learning algorithms and insights from condition monitoring engineers, AssetWatch transforms data into actionable intelligence, enabling manufacturers to adopt a proactive maintenance culture. Their approach enhances the predictive maintenance process with expert prescriptive recommendations that go beyond standard evaluations, thereby supporting organizations in shifting from reactive to proactive maintenance and reliability strategies.

Quince, LLC, established in 2016 and headquartered in San Francisco, California, is a retailer specializing in affordable luxury apparel, accessories, and home goods. The company offers a wide range of products for men and women, including jewelry, clothing, and home textiles, all sourced directly from manufacturers using a just-in-time production model. This approach enables Quince to provide high-quality items at competitive prices while minimizing waste.

Maza is a mobile application that operates as a digital bank, providing a range of modern banking services. The company offers users access to savings accounts, NFC-enabled prepaid cards for both online and offline transactions, as well as bill payment and money transfer services. Maza aims to deliver a seamless banking experience, allowing users to manage their finances efficiently while maximizing their savings. Through its innovative approach, the company seeks to enhance the way individuals engage with their financial products and services.

Binkey is a financial technology company that helps merchants to accepts FSA and HSA as a form of payment.

Tabby Inc. is a financial technology company based in the United Arab Emirates that offers innovative payment solutions for online and offline shopping. The company specializes in a buy now, pay later service, providing consumers in the UAE and Saudi Arabia with flexible payment options. Customers can choose to pay for their purchases either in a single deferred payment or in multiple installments, allowing them to manage their spending and enhance their shopping experience. Through its platform, Tabby aims to reshape the relationship between consumers and money, promoting financial freedom and responsible spending.

Avalyn Pharma, Inc. is a biopharmaceutical company focused on developing innovative therapies for idiopathic pulmonary fibrosis (IPF) and other serious respiratory conditions. Headquartered in Seattle, Washington, with an additional office in San Diego, the company specializes in an inhaled formulation of pirfenidone, known as AP01. This formulation aims to enhance the amount of medication that reaches the lungs while minimizing side effects associated with oral treatments. Established in 2011, Avalyn Pharma is dedicated to improving care and outcomes for patients with severe respiratory diseases through its advanced therapeutic pipeline and novel inhaled therapeutics. Initially named Genoa Pharmaceuticals, the company rebranded to its current name in July 2017.

Fore Biotherapeutics is a clinical-stage biotechnology company focused on developing precision oncology treatments for cancer patients with specific genetic mutations. By utilizing functional genomics, the company aims to create a pipeline of targeted therapies that address unmet medical needs in oncology. Their drug development process involves replicating naturally occurring mutations in laboratory settings, allowing for the testing of these mutations' effects on signaling pathways and their responsiveness to various compounds. This approach not only facilitates the identification of novel target mutations but also helps biopharmaceutical companies expand the subgroups of cancer patients who may benefit from existing therapies.

Trove is a technology company based in Ann Arbor, Michigan, and Brisbane, California. It operates two distinct businesses: a SaaS platform that uses AI to analyze teams' email connections, providing insights to help build and leverage professional networks; and a leading platform for branded resale and trade-in, enabling brands to launch, manage, and scale their resale programs efficiently. The latter offers advanced tools for in-store and digital trade-ins, returns processing, inventory management, resale site building, and analytics, serving prominent brands like Canada Goose, Carhartt, and Patagonia. Trove's resale platform aims to drive sustainability in retail by promoting a circular economy.

SKIMS is a brand focused on creating innovative underwear, loungewear, and shapewear designed to enhance body shape. The company manufactures and retails a diverse array of products, including bodysuits, shapewear, and various styles of underwear. SKIMS offers a broad selection of colors and sizes to cater to different body types, ensuring that women receive both the support and coverage they need. By prioritizing inclusivity and functionality, SKIMS aims to address the diverse needs of its customers in the intimate apparel market.

Musinsa Co., Ltd. is a fashion-focused company based in Seoul, South Korea, established in 2012. It operates both online and offline, offering a diverse range of products that include apparel, footwear, accessories, cosmetics, and more. Musinsa serves as a platform for various brands, including subculture, national, and global sports brands, providing customers with curated content, styling pictorials, and information on fashion trends. The company emphasizes customer engagement by allowing users to interact with brands and access personalized curation and storytelling. Additionally, Musinsa publishes an online fashion web magazine that showcases product information and brand highlights, further enriching the fashion culture and consumption experience in the Korean market.

Orennia is a provider of commercial analytics focused on the renewable and zero-carbon energy sectors. The company offers a platform that aggregates and cleanses extensive data related to commercial, engineering, pricing, transmission facilities, and demand. By leveraging advanced technology and insights from seasoned industry experts, Orennia aims to assist investors in making informed capital allocation decisions, ultimately accelerating their time-to-value in the renewable power sector. The company's objective insights enable clients to navigate investment opportunities effectively and with confidence in this rapidly evolving market.

Caraway is a digital healthcare company focused on providing integrated mental, reproductive, and physical healthcare services specifically for college women. Designed with input from students, Caraway delivers a personalized and equitable care solution that addresses the unique needs and concerns of women during a crucial developmental period. The platform emphasizes accessible and compassionate healthcare, recognizing the growing demand for mental health resources and the persistent inequities in women's health. By offering trusted and holistic care, Caraway empowers college students to effectively manage their health in a complex and often challenging healthcare landscape.

Upstream Bio Inc is a clinical-stage biotechnology company dedicated to developing treatments for inflammatory diseases, particularly severe respiratory disorders. The company's primary focus is on verekitug, an antibody therapy designed to inhibit the Thymic Stromal Lymphopoietin receptor. This receptor is a key target in the inflammatory response, influencing various immune cells and signaling pathways involved in both common and rare illnesses. By targeting TSLP, Upstream Bio aims to address the underlying mechanisms of severe asthma and related conditions, positioning itself as a significant player in the field of immunotherapy.

Alkeus Pharmaceuticals is a clinical-stage biopharmaceutical company based in Boston that specializes in developing treatments for serious ophthalmic conditions. The company's primary focus is on addressing untreatable diseases of the eye, with its lead drug candidate being an orally delivered compound aimed at treating Stargardt disease and age-related macular degeneration. Through its innovative approach, Alkeus aims to empower medical professionals to manage symptoms of irreversible vision loss at an earlier stage in affected patients.

EVgo Services LLC, established in 2010 and headquartered in Los Angeles, specializes in operating a network of fast-charging stations for electric vehicles (EVs) across the United States. The company's infrastructure is compatible with all fast-charge capable EV models, providing up to 90 miles of range in just 30 minutes. EVgo partners with various businesses and organizations, such as grocery stores, automotive manufacturers, and local governments, to strategically place its charging stations, ensuring convenience and accessibility for EV drivers.

Boundless Bio, Inc. is a clinical-stage biopharmaceutical company based in La Jolla, California, focused on developing innovative therapies for the treatment of aggressive cancers. The company specializes in targeting extrachromosomal DNA (ecDNA), a key factor in the amplification of oncogenes that affects over 14% of cancer patients. By investigating the biology of ecDNA, Boundless Bio aims to create transformative treatments for previously untreatable cancers. Its lead therapeutic candidate, BBI-355, is an oral selective inhibitor of checkpoint kinase 1 (CHK1) designed to manage the replication and transcription of ecDNA in cancer cells. Founded in 2018, Boundless Bio is committed to addressing the significant unmet medical needs of patients with oncogene amplified tumors.

Quince, LLC, established in 2016 and headquartered in San Francisco, California, is a retailer specializing in affordable luxury apparel, accessories, and home goods. The company offers a wide range of products for men and women, including jewelry, clothing, and home textiles, all sourced directly from manufacturers using a just-in-time production model. This approach enables Quince to provide high-quality items at competitive prices while minimizing waste.

AMP Robotics Corporation specializes in designing and manufacturing robotic systems for material recovery facilities and recycling operations, focusing on automating the identification, sorting, and processing of complex waste streams. The company's flagship product, AMP Cortex, utilizes advanced robotics and computer vision technology to efficiently pick and sort recyclable materials, significantly lowering sorting costs. Additionally, AMP Neuron, a software solution, captures and analyzes material data to identify features in a manner similar to human perception. By leveraging artificial intelligence and machine learning, AMP Robotics enhances recycling processes for various waste types, including municipal solid waste and e-waste. The modular design of its systems allows for easy integration into existing infrastructure, minimizing disruption and capital investment. Founded in 2014 and headquartered in Louisville, Colorado, AMP Robotics has formed strategic partnerships to further its mission of improving recycling rates and economic recovery of recyclables.

Clerkie is an AI-driven financial planning company that focuses on helping individuals manage their debt more effectively. It offers a proprietary financial automation platform that leverages conversational AI to create detailed financial knowledge graphs. This technology enables users to receive personalized answers and actionable plans tailored to their financial situations. By combining expert financial advice with automated processes, Clerkie aims to simplify the management of debt for its users, making it easier for them to take proactive steps towards alleviating their financial burdens. The platform serves both consumers seeking financial guidance and creditors looking to manage loan losses effectively.

Saluda Medical Pty Ltd. is a medical device company specializing in the development of neuromodulation technologies for chronic neurological conditions. Founded in 2010 and based in Artarmon, Australia, with additional offices in the United States and the United Kingdom, Saluda Medical focuses on its innovative Evoke system. This investigational device employs a closed-loop spinal cord stimulation approach that continuously monitors the spinal cord's response to stimulation and adjusts treatment in real-time to optimize patient outcomes. By utilizing a unique dose-control platform, Saluda Medical aims to customize therapy based on individual neural responses, thereby improving the management of chronic pain, particularly in patients suffering from conditions such as neuropathic pain and chronic back pain.

HeartFlow Inc., established in 2007 and headquartered in Redwood City, California, specializes in non-invasive coronary artery detection solutions. The company's flagship product, HeartFlow Analysis, employs artificial intelligence to generate a personalized 3D model of the heart using standard CT scan data. This enables clinicians worldwide to assess the impact of blockages on blood flow and determine optimal patient treatment, thereby reducing unnecessary invasive testing. HeartFlow operates additional offices in Portland (Oregon), Austin (Texas), London (UK), and Tokyo (Japan).

Span.IO is a company focused on advancing the adoption of renewable energy through innovative technology solutions for residential energy management. The firm develops a smart electrical panel that replaces traditional panels, allowing homeowners to monitor and control their energy usage seamlessly via a dedicated application. This device not only facilitates the efficient use of renewable electricity but also supports electric vehicle charging, enhancing the overall consumer experience. Span.IO's team comprises engineers with expertise in power generation, energy conversion, controls, and system integration, who are committed to creating products that positively impact the environment while providing users with greater visibility and control over their energy consumption.

Chroma Medicine is a genomic medicine company founded in 2021 and based in Cambridge, Massachusetts, specializing in epigenetic editing. The company is pioneering a new class of genomic therapies aimed at revolutionizing the treatment of genetically driven diseases. By utilizing epigenetics, which is the natural mechanism for gene regulation, Chroma Medicine develops programmable epigenetic editors that target specific genes and modulate chromatin conformation. This innovative approach enables healthcare providers to achieve precise control of gene expression, offering a promising therapeutic option for conditions linked to genetic anomalies.

Cargo Therapeutics is a clinical-stage biotechnology company focused on developing innovative CAR T-cell therapies to improve outcomes for cancer patients. The company aims to address the challenges faced by existing autologous CAR therapies, which are only curative for less than half of cancer patients and hindered by issues such as manufacturing limitations, supply challenges, and reimbursement barriers. Cargo Therapeutics is advancing next-generation cell therapies designed to enhance effectiveness, safety, and supply reliability. One of its key products, CRG-022, is a novel CAR T-cell candidate targeting CD22, an antigen present in a majority of B-cell malignancies, specifically designed to overcome treatment resistance. By pursuing these novel solutions, Cargo Therapeutics seeks to facilitate broader access to curative therapies and significantly improve the treatment experience for cancer patients.

Dataiku Inc. is a data platform company that specializes in artificial intelligence and machine learning, facilitating businesses in their data journey from analytics to enterprise AI. Founded in 2013 and headquartered in New York, with additional offices in Paris and London, Dataiku develops the Dataiku DSS, a collaborative software platform designed for data scientists, analysts, and engineers. This platform enables users to prepare, analyze, and visualize data, allowing for interactive exploration and the application of machine learning technologies through a user-friendly interface. By providing a centralized environment that fosters collaboration and best practices, Dataiku aids organizations in overcoming challenges in data management and deployment, leading to more efficient and impactful data-driven solutions. Notable clients include Unilever, GE, and FOX News Group, who leverage Dataiku to accelerate their data initiatives and enhance their operational capabilities.

Apogee Therapeutics is a San Francisco-based biotechnology company founded in 2022, specializing in the development of novel therapies for immunological and inflammatory disorders. The company focuses on creating differentiated biologics to treat conditions such as atopic dermatitis and chronic obstructive pulmonary disease, addressing significant unmet medical needs. Apogee's approach involves advancing antibody programs designed to target established mechanisms of action while utilizing advanced engineering techniques to enhance the therapeutic properties, including extended half-life. The company is actively developing two main programs: APG777 for atopic dermatitis and APG808 for chronic obstructive pulmonary disease.

Rokt is a software development company that specializes in e-commerce technology aimed at enhancing the consumer purchasing experience. By integrating marketing directly into the transaction moment, Rokt connects advertisers to customers, allowing for the placement of native advertisements within the transactional flows of e-commerce sites. This strategic positioning occurs at a time when consumers are most receptive to marketing messages, enabling e-commerce operators to increase revenue while providing a more effective customer experience. Rokt's solutions not only facilitate greater social engagement but also promote higher cross-selling opportunities for brands, thereby transforming the landscape of online shopping.

MBX Biosciences, Inc. is a biotechnology company founded in 2018 and based in Carmel, Indiana. The company specializes in developing therapeutics for rare endocrine disorders, focusing on conditions that currently lack effective treatments. MBX Biosciences aims to discover, develop, and commercialize first-in-class therapies, particularly peptides designed to address endocrine genetic diseases that affect glandular hormone production and the body’s chemical messaging systems.

Zenas BioPharma is a clinical-stage biopharmaceutical company headquartered in Florida, USA, that specializes in developing immune-based therapies for patients. The company’s lead product candidate, obexelimab, is a bifunctional monoclonal antibody designed to target both CD19 and FcγRIIb, which are found in B cell lineages. This innovative approach aims to inhibit the activity of cells involved in various autoimmune diseases while preserving their presence, thus avoiding depletion. Through its focus on these advanced therapies, Zenas BioPharma seeks to address unmet medical needs in the treatment of autoimmune conditions.

AMP Robotics Corporation specializes in designing and manufacturing robotic systems for material recovery facilities and recycling operations, focusing on automating the identification, sorting, and processing of complex waste streams. The company's flagship product, AMP Cortex, utilizes advanced robotics and computer vision technology to efficiently pick and sort recyclable materials, significantly lowering sorting costs. Additionally, AMP Neuron, a software solution, captures and analyzes material data to identify features in a manner similar to human perception. By leveraging artificial intelligence and machine learning, AMP Robotics enhances recycling processes for various waste types, including municipal solid waste and e-waste. The modular design of its systems allows for easy integration into existing infrastructure, minimizing disruption and capital investment. Founded in 2014 and headquartered in Louisville, Colorado, AMP Robotics has formed strategic partnerships to further its mission of improving recycling rates and economic recovery of recyclables.

immatics is a biopharmaceutical company focused on the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors. The company's customized Adoptive Cell Therapies (ACTengine) and antibody-like TCR Bispecifics are the two main product classes in the pipeline (TCER). With a focus on particularly difficult-to-treat solid malignancies, each therapy modality has unique characteristics to create the desired therapeutic impact for patients at various disease stages and with various types of tumors. immatics biotechnologies was established in 2000 by Hans Rammensee, Harpreet Singh, and Steffen Walter in Tübingen, Baden-Wurttemberg.

RayzeBio, Inc. is a biotechnology company based in San Diego, California, founded in 2020. The company specializes in developing tumor-targeted small molecule medicines that leverage radioisotopes to improve cancer treatment outcomes. RayzeBio focuses on creating innovative radiopharmaceuticals, particularly utilizing alpha-emitting radioisotopes like Actinium-225, to target solid tumors effectively. With a robust pipeline of drug candidates, RayzeBio is committed to addressing significant market opportunities in oncology through late-stage clinical programs, development initiatives, and discovery efforts. The company's mission is to provide effective therapeutic solutions aimed at defeating cancer.

Flavrs is an innovative shoppable video platform based in San Francisco, California, that seamlessly integrates premium food content with commerce. Founded in 2020, the company focuses on providing food enthusiasts with engaging video recipe tutorials created in collaboration with renowned chefs and food creators. Users can explore a wide variety of recipes, including seafood, Thai, Chinese, and appetizers, all while having the capability to shop for the necessary ingredients directly through the platform. This custom integration with a grocery delivery service allows foodies to easily replicate the meals they see in the tutorials at home, enhancing their culinary experience.

SeatGeek, Inc. is a mobile ticketing marketplace and ticket search engine that facilitates the buying and selling of tickets for sports, concerts, and theater events. Founded in 2009 and headquartered in New York, the company also maintains offices in the United Kingdom, Israel, the Netherlands, Australia, and Italy. SeatGeek's platform aggregates ticket listings from various sources, presenting users with a comprehensive view of available options. It employs a unique feature called 'Deal Score,' which rates tickets on a scale from 0 to 100, helping consumers identify the best value for their purchases. Additionally, SeatGeek offers an event discovery tool that utilizes user preferences to suggest local events that align with individual tastes. By streamlining the ticketing process and providing detailed information about venues and pricing, SeatGeek aims to enhance the overall experience for fans.

Meati Foods is a consumer goods company based in Boulder, Colorado, that specializes in the production and sale of fungi-based meat alternatives. Founded in 2016, the company aims to provide nutrient-dense, plant-based options that serve as sustainable substitutes for traditional meat. Meati's products are crafted using proprietary fermentation technologies and are minimally processed, ensuring they are free from common allergens. The company is committed to offering vegan food choices that are accessible and enjoyable for a diverse range of consumers.

Moving Analytics is a telehealth service provider that specializes in cardiovascular prevention programs. Its first product Movn is an end-to-end, integrated program to deliver remote and virtual cardiac rehab. The platform reduces readmissions and empowers the effective and efficient delivery of quality care to patients based on 30+ years of research in remote disease management from Stanford University.

FalconX, Ltd. is a cryptocurrency brokerage and digital asset trading platform founded in 2018 and based in San Mateo, California. The company specializes in blockchain technology and fintech, offering clients access to cryptocurrency markets for trading, credit, and clearing. FalconX utilizes data science and machine learning to ensure reliable execution of mid-to-large size trades, smart routing prices across multiple liquidity sources. This approach helps eliminate slippage and hidden fees, making it an attractive option for hedge funds, proprietary trading firms, and other institutional clients seeking efficient and cost-effective trading solutions.

Kinside Inc., founded in 2018 and based in Pasadena, California, operates a dual-sided childcare platform that connects working parents with a network of daycares and preschools across the United States. The application enables parents to find and secure childcare options while offering the ability to pay for care online. Kinside's platform provides a comprehensive range of childcare services, allowing parents to access current openings and explore various options. Additionally, it facilitates employer contributions and tax savings, thereby creating a transparent and affordable solution for working families seeking reliable childcare.

Guild Education, Inc. is an educational technology company founded in 2015 and headquartered in Denver, Colorado. The company provides a lifelong learning platform designed for working adults, offering a range of online courses, workshops, and educational programs. These include bachelor’s and master’s degrees, high school diplomas, certificate programs, and language learning opportunities. Guild Education supports its users throughout their educational journey by utilizing a technology platform that facilitates discovery and learning, as well as a tech-enabled student advising model to enhance the overall experience. The company aims to empower adults to advance their education and career paths effectively.

Arcadia, Inc. is a technology company based in Washington, D.C., founded in 2014, that focuses on providing access to clean energy solutions. Through its platform, Arc, the company connects subscribers to renewable energy sources such as wind farms and community solar projects. By enabling users to manage their accounts, track energy usage, and participate in clean energy initiatives, Arcadia aims to democratize access to renewable energy and combat the fossil fuel monopoly. The platform aggregates energy data from over 125 utilities, representing more than 80% of U.S. electric utility accounts, thus facilitating a significant shift toward sustainable energy practices. Additionally, Arcadia's community solar program addresses energy injustice while promoting economic growth, contributing over five Terawatt-hours of energy demand from residential and commercial users.

Span.IO is a company focused on advancing the adoption of renewable energy through innovative technology solutions for residential energy management. The firm develops a smart electrical panel that replaces traditional panels, allowing homeowners to monitor and control their energy usage seamlessly via a dedicated application. This device not only facilitates the efficient use of renewable electricity but also supports electric vehicle charging, enhancing the overall consumer experience. Span.IO's team comprises engineers with expertise in power generation, energy conversion, controls, and system integration, who are committed to creating products that positively impact the environment while providing users with greater visibility and control over their energy consumption.

Omada Health, Inc. is a digital healthcare company that specializes in developing online programs aimed at managing chronic conditions. Founded in 2011 and headquartered in San Francisco, California, with an additional office in Atlanta, Georgia, Omada focuses on preventing conditions such as prediabetes, diabetes, hypertension, and heart disease. The company provides personalized digital health programs that cater to the unique needs of individuals, utilizing professional health coaching, connected health devices, and real-time data to facilitate meaningful health improvements. Omada is recognized as the largest provider of the National Diabetes Prevention Program, empowering individuals to engage actively in their health and achieve sustainable lifestyle changes. The platform also addresses behavioral health issues, including anxiety and depression, further supporting individuals in their overall wellness journey.

Somatus, Inc. is a healthcare company focused on providing specialized kidney care services aimed at delaying or preventing the progression of chronic kidney disease. Founded in 2016 and headquartered in McLean, Virginia, Somatus collaborates with health plans, health systems, nephrology, and primary care groups to deliver integrated care for patients with or at risk of kidney disease. Its comprehensive services include home hemodialysis, peritoneal dialysis, in-center hemodialysis, kidney transplant, and conservative care. By utilizing vertically integrated clinical services and technology, Somatus seeks to improve patient outcomes, enhance care coordination, and promote the use of home dialysis modalities while increasing the rates of kidney transplantation. The company's mission is to ensure that patients can access the care they need to manage kidney disease effectively.

Synthego Corporation is a genome engineering company that specializes in accelerating life science research and development to enhance human health. Established in 2012 and headquartered in Redwood City, California, Synthego utilizes an innovative platform that integrates hardware, software, bioinformatics, chemistries, and molecular biology. This full-stack approach provides researchers with tools for gene editing, including engineered cells, CRISPR kits, and bioinformatics for guide RNA optimization and analysis. The products support various applications in basic research, therapeutic development, disease modeling, and diagnostics. Synthego serves a diverse range of customers, including biotechnology firms, universities, and therapeutic developers worldwide, distributing its offerings online and through partners in multiple countries. By leveraging automation and machine learning, Synthego enables genetic engineers and medical professionals to conduct research that is both rapid and cost-effective.

Creditas is a financial technology company that operates a digital platform that offers secured consumer loans. It uses credit scoring systems and borrowers’ assets, such as homes and automobiles as collateral to offer loans. Sergio Furio founded BankFacil in 2012 that later became Creditas. It has its headquarters in São Paulo in Brazil.

CodeSee is a developer of cloud-based data visualization software aimed at enhancing code comprehension for developers and development teams. Founded in 2019 and based in San Francisco, California, the company provides tools that facilitate a continuous understanding of the codebase throughout the development process. Its software enables users to visualize how various elements of code and functionality are interconnected, thereby improving the overall workflow and efficiency of software development.

Go Digit General Insurance Limited is a Bengaluru-based insurance provider that utilizes a digital platform to offer a wide range of insurance products. Founded in 2016 and formerly known as Oben General Insurance Limited, the company provides services including car, travel, home, commercial vehicle, shop, bike, health, and mobile insurance, as well as group health and flight delay insurance. Go Digit General Insurance is known for its customer-centric approach, focusing on claims processing, renewals, and garage services. The company generates most of its revenue from motor insurance products, catering primarily to the Indian market. As a subsidiary of Go Digit Infoworks Services Private Limited, it aims to innovate in product design and pricing strategies.

Dave Inc. is a financial services company that has developed a mobile application designed to assist users in managing their finances and avoiding bank overdrafts. Founded in 2015 in Los Angeles, the app provides features such as expense prediction, overdraft alerts, and the ability to access paycheck advances, allowing users to maintain a healthy balance. With a focus on financial wellness, Dave offers services including a $250 overdraft protection, credit building tools, and opportunities to find additional income sources. The company has rapidly gained popularity, amassing over 12 million members and positioning itself as a disruptive force in the banking sector by providing transparent financial products without hidden fees. The app serves as a digital support system for individuals seeking budgeting advice and immediate financial assistance, akin to the support one might receive from a friend or family member.

Taqanal Energy is a company focused on transitioning away from fossil fuels and internal combustion engines by providing an Intelligent Energy Storage Management System. This system combines embedded intelligence in batteries with cloud-based applications, facilitating effective management of energy assets. Taqanal Energy's platform supports various applications, including battery swapping and charging stations, as well as renewable energy solutions. By enhancing asset management and operational efficiency, the company aims to contribute to a more sustainable energy landscape.

Rokt is a software development company that specializes in e-commerce technology aimed at enhancing the consumer purchasing experience. By integrating marketing directly into the transaction moment, Rokt connects advertisers to customers, allowing for the placement of native advertisements within the transactional flows of e-commerce sites. This strategic positioning occurs at a time when consumers are most receptive to marketing messages, enabling e-commerce operators to increase revenue while providing a more effective customer experience. Rokt's solutions not only facilitate greater social engagement but also promote higher cross-selling opportunities for brands, thereby transforming the landscape of online shopping.

Anchorage Digital is a regulated cryptocurrency platform that offers integrated financial services and infrastructure solutions tailored for institutions. Established in 2017 and headquartered in San Francisco, California, the company operates as the only federally chartered crypto bank in the United States, with an additional office in Singapore that maintains similar security and service standards. Anchorage Digital specializes in secure custody, regulatory compliance, and a variety of cryptocurrency-related services, including trading, staking, and governance. The platform emphasizes modern security engineering to ensure the safety of digital assets while facilitating streamlined participation in blockchain technology for businesses and institutions. With a valuation exceeding $3 billion, Anchorage Digital has attracted investments from prominent firms such as Andreessen Horowitz, Goldman Sachs, and Visa, among others. The company also supports a remote-friendly work environment, with additional offices located in New York, Porto, and Sioux Falls.

Juspay Technologies Pvt Ltd. is a Bengaluru-based company, founded in 2012, that specializes in mobile payment solutions. It offers a suite of products, including JUSPAY SAFE, a mobile payments browser, and EXPRESS CHECKOUT, which enhances payment gateway performance. The company's online platform serves as a software-as-a-service layer over existing payment gateways, streamlining integration and improving the management of various payment options. This enables users to conduct electronic transactions securely and efficiently, catering to the evolving needs of mobile-based payments.

Olist is a Brazilian company headquartered in Curitiba that operates an online e-commerce platform designed to facilitate sales for small and medium-sized businesses (SMBs). It acts as a commerce enabler by connecting entrepreneurs to major online marketplaces, allowing them to advertise and sell their products seamlessly. Olist's offerings include Olist Store, which helps merchants sell on various marketplaces, and Olist Shops, a mobile-first e-commerce solution integrated with social media and accessible in 180 countries. Additionally, Olist provides logistics services through Olist Pax, a cloud-based network that supports fulfillment in Brazil, and financial services through Olist Credit and Olist Pay, assisting SMBs with their capital needs. As a leading commerce enabler, Olist is expanding its reach beyond Brazil to serve the global market.

Learneo brands and platforms are pioneering advances in a wide range of applications for emergent technologies, including the use of AI to improve people's writing, reading and math skills, in school, professional and daily life. The platform of businesses includes CliffsNotes, the original and iconic study guide company; Course Hero, an online learning platform of academic resources; LitCharts, a creator of literature resources; QuillBot, an AI-powered writing companion helping anyone improve their writing skills; Scribbr, a multilingual academic proofreading service, and Symbolab, an AI-based mathematics resource. Learneo was established in Redwood City, California by Andrew Grauer and Gregor Carrigan.

Chroma Medicine is a genomic medicine company founded in 2021 and based in Cambridge, Massachusetts, specializing in epigenetic editing. The company is pioneering a new class of genomic therapies aimed at revolutionizing the treatment of genetically driven diseases. By utilizing epigenetics, which is the natural mechanism for gene regulation, Chroma Medicine develops programmable epigenetic editors that target specific genes and modulate chromatin conformation. This innovative approach enables healthcare providers to achieve precise control of gene expression, offering a promising therapeutic option for conditions linked to genetic anomalies.

Faire is an online wholesale marketplace that connects retailers with unique merchandise while enabling brands to reach local stores. The platform is designed to alleviate the inventory risk often associated with wholesale purchasing, offering features such as net 60 payment terms and free returns. This approach allows local retailers and independent brands to compete effectively against larger competitors. Utilizing artificial intelligence and predictive analytics, Faire helps retailers forecast product demand and streamline inventory management, reducing the time and resources needed to source goods. Headquartered in San Francisco, California, and Kitchener, Ontario, Faire supports the growth of local retail through its innovative technology and data-driven insights.